| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 320,458 | 243,034 |
| Net increase (decrease) in cash and cash equivalents | 1,359 | 4,664 |
| Cash and cash equivalents at beginning of period | 8,952 | - |
| Cash and cash equivalents at end of period | 10,311 | - |
Semler Scientific, Inc. (SMLR)
Semler Scientific, Inc. (SMLR)